Search Results 2131-2140 of 21363 for anti-TNF drugs

  1. Brimonidine And Timolol (Ophthalmic Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Trastuzumab-Anns (Intravenous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Trastuzumab-anns injection is used together with other cancer medicines (eg, doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, or ...

  3. Beyond the status quo: Technical advances in managing brain tumors - Mayo Clinic

    Proton therapy and future carbon ion treatment for brain tumors. Restorative and exoscopic neurosurgeries. Before adopting new technologies, Mayo Clinic ...

  4. Teclistamab-Cqyv (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Drugs and Supplements · Teclistamab-Cqyv ... treatment) multiple myeloma in patients who have received at least 4 previous treatment. ... anti-CD38 monoclonal ...

  5. Publications - Dan S. Childs, M.D. - Mayo Clinic

    Metastasis-directed therapy for metachronous lung metastases in prostate cancer JU Open Plus. 2023. Riaz IB, Naqvi SAA, He H, Asghar N, Siddiqi R, Liu H, Singh ...

  6. Naloxone (Nasal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Venetoclax (Oral Route) Proper Use - Mayo Clinic

    This medicine comes with a Medication Guide. Read and follow these instructions carefully. Ask your doctor if you have any questions. Take this medicine with ...

  8. Entecavir (Oral Route) Proper Use - Mayo Clinic

    Read and follow carefully the patient information leaflet before starting entecavir treatment and each time you refill. Ask your doctor or pharmacist if you ...

  9. A Study to Evaluate TG4050 in Ovarian Carcinoma - Mayo Clinic

    By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA-4. Patients with ... Patients under chronic treatment with systemic corticosteroids or other ...

  10. Publications - Lionel A. Kankeu Fonkoua, M.D. - Mayo Clinic

    Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.